Article
A hypomorphic model of CPS1 deficiency for investigating the effects of hyperammonemia on the developing nervous system.
Disease models & mechanisms - 1 Jul 2025
Bakshi Stuti, Diep Taryn, Willis Brandon J, Reyes Rachel, Wu Grace F, Makris Georgios, Poms Martin, Day Isabel, Sun Qin, Zhuravka Irina, Lueptow Lindsay, Tang Michelle, Cromie Gareth A, Dudley Aimée M, Häberle Johannes, Lipshutz Gerald S
Abstract excerpt
Carbamoyl phosphate synthetase 1 (CPS1) deficiency is a rare metabolic disorder that, in neonatal onset, is typically characterized by severe life-threatening and neurologically injuring hyperammonemic episodes with high unmet patient need. Patients that retain limited enzyme activity may present later in life with less severe hyperammonemia. CPS1 drives the first step in the urea cycle, the pathway terrestrial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
